To the best of our knowledge, this the first study to investigate the prognostic utility of DBN1 in luminal breast cancer using large clinical data sets with long-term follow up, which suggest DBN1 as a possible prognostic marker in patients with luminal tumours. Here, DBN1 is linked to breast carcinoma.